French regulator fines Novo, Lilly over obesity drug promotion

Clinical OMICsProtein Biomarkers in Practice: Strategies to Reduce Drug Development Risk

Clinical OMICsMayo Clinic’s REDMOD AI Doubles Early Detection Sensitivity in Pancreatic Cancer

FierceBiotechIpsen scuttles liver disease candidates from $952M Albireo acquisition

AmgenBiopharma Manufacturing Expands in the U.S.: Amgen, Lilly Double Down on Capacity and Next-Gen Production - BioPharm International

Endpoints NewsAmgen, AbbVie say IRA negotiations impacted Q1 sales

Clinical OMICsAt-Home Blood Test Screens for Early Dementia

Clinical OMICsGlioblastoma: Testosterone Supplements Linked to 38% Lower Risk of Death

Endpoints NewsLilly plans new $4.5B manufacturing investment in Indiana

Endpoints NewsBeOne culls five cancer programs and an autoimmune Phase 2

Endpoints NewsLonza looks to ride ADC wave with upcoming factory, workforce expansion

FierceBiotechBipartisan PRIMATE Act aims to ban monkey imports to US

Clinical OMICsEarly Glucagon Elevation Linked to MASLD in Type 2 Diabetes